Neuren Pharmaceuticals (ASX:NEU) has announced it will develop its drug candidate NNZ-2591 to treat hypoxic-ischemic encephalopathy (HIE), a severe brain injury affecting newborns due to lack of ...
Birth injuries can take an emotional toll on both the child and the parents. For the child, the consequences can include ...
The ASX 200 biotech stock notes that HIE is a devastating type of brain injury caused when a baby's brain does not receive ...
Stockhead on MSN11h
Health Check: ASX ‘Magnificent Seven’ rides high amidst the US healthcare mayhemAmid the downbeat narrative about US healthcare policy and cuts to funding agencies, a ‘Magnificent Seven’ of ASX drug ...
Thirteen years after Sherman Kirby Quisses's death, an inquest jury has determined it was a homicide, in a case that saw a ...
These shares are avoiding the market weakness on Thursday. But why? The post Why Core Lithium, Healius, Neuren, and Reject ...
On March 25, 2025, a St. Louis County jury rendered a $48.1 million verdict to a permanently brain injured child of a woman who was a nurse at Mercy Hospital when Dr. Daniel McNeive, a Mercy Clinic ...
Neuren Pharmaceuticals has announced it will develop a new drug to treat a type of life-threatening brain injury in infants, ...
Newsner on MSN22h
Breastfeeding technique leads to death of 7-week-old babyI never imagined that something as natural as breastfeeding could pose a danger to a baby – but now a parenting charity is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback